Executive
MANAGEMENT
Left to right: Vikash Singh, Bertina Engelbrecht, Vikesh Ramsunder, Trevor McCoy and Michael Fleming
Vikesh Ramsunder (50)
Chief executive officer
B Com, MBL
Joined the group in 1993
Appointed as chief executive officer in January 2019
- Chief operating officer of Clicks from 2015 to 2018.
- Managing director of UPD from 2010 to 2015, where he was instrumental in driving UPD’s integrated pharmaceutical wholesale and distribution strategy.
- Served in store, logistics and management positions across the group since joining the group in 1993.
Michael Fleming (54)
Chief financial officer
B Com, CTA, CA (SA)
Joined the group in February 2011
- Previously chief financial officer of Tiger Brands Limited.
- Joined the Tiger Brands group in 2000, appointed as financial executive of the Tiger Brands consumer brands division in 2005 and promoted to chief financial officer in June 2008.
Bertina Engelbrecht (58)
Group corporate affairs director
B Proc, LL M, admitted attorney
Joined the group as group human resources director in March 2006
- Appointed chief executive officer from January 2022.
- Responsibilities expanded in December 2020 to include strategic stakeholder engagement.
- Previously general manager for Shell SA Energy and regional human resources manager for Shell Oil Products Africa.
- Prior to this she was director of organisational effectiveness at Sea Harvest, managed her own consultancy practice and spent eight years with Transnet.
Vikash Singh (48)
Managing executive: Clicks
B Com (Acc), MBA
Joined the group in 2006
Appointed as managing executive in February 2021
- Managing executive of UPD from 2015 to 2021.
- Career has spanned financial, operational, supply chain and logistics responsibilities, with extensive experience in logistics management in both Clicks and UPD.
Trevor McCoy (51)
Managing executive: UPD
B Sc, PGDMM, MBA
Joined the group in April 2021
- Previously head of public affairs for Sanofi South Africa.
- 25 years’ experience in the pharmaceutical sector.
- Previous roles include serving as business unit head in diverse portfolios and therapeutic classes in Sanofi, Pfizer and Alcon.